Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01818661 · ClinicalTrials.gov registry record · Phase 4

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

A Phase 4 study of Primary Progressive Aphasia and Apraxia of Speech, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 4
Development phase
50
Enrollment target
1
Study location

NCT01818661 is a Phase 4 study of Primary Progressive Aphasia and Apraxia of Speech that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 89-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01818661, a Phase 4 study of Primary Progressive Aphasia and Apraxia of Speech, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 4
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).

Conditions Studied

Primary Progressive Aphasia Apraxia of Speech Non-fluent Aphasia PPA Primary Progressive Non-fluent Aphasia

Interventions

  • DRUG AV-1451

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-07-01
Est. Completion 2028-06
Phase Phase 4

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01818661

The ClinicalTrials.gov registry entry for NCT01818661 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (44% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 1 intervention - of which AV-1451 is the first listed.

NCT01818661 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01818661 about?

NCT01818661 is a clinical study titled "Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech". The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).

What is the current status of trial NCT01818661?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-07-01. Estimated completion is 2028-06.

What conditions does trial NCT01818661 study?

This clinical trial studies the following conditions: Primary Progressive Aphasia, Apraxia of Speech, Non-fluent Aphasia, PPA, Primary Progressive Non-fluent Aphasia.

What interventions are being tested in trial NCT01818661?

The interventions under investigation include: AV-1451 (DRUG).

Who is sponsoring clinical trial NCT01818661?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01818661 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Progressive Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Progressive Aphasia

All registered trials for this condition

Apraxia of Speech

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.